Dendritic Cells (DCs) are crucial components of the immune system with the primary function of capturing, processing, and presenting antigens to activate T cells. These specialized antigen-presenting cells are distributed throughout tissues, acting as sentinels that survey the environment for foreign invaders. Dendritic cells are characterized by their elaborate, branched extensions called dendrites, which enhance their ability to capture antigens efficiently. Upon encountering pathogens, DCs internalize antigens, process them into smaller fragments, and present these fragments on their cell surface using major histocompatibility complexes (MHC). Dendritic cells play a pivotal role in initiating and shaping immune responses. They act as a bridge between the innate and adaptive immune systems by presenting antigens to T cells, which then trigger immune reactions against specific pathogens. DCs also participate in immune tolerance, preventing inappropriate immune responses against self-antigens and contributing to immune system homeostasis. Research on dendritic cells has led to significant insights into vaccine development, as their unique ability to initiate immune responses makes them key targets for harnessing protective immunity. Dysregulation of dendritic cell function is associated with autoimmune diseases, allergies, and certain infections. Understanding the biology of dendritic cells provides opportunities for developing immunotherapies and interventions to modulate immune responses for therapeutic purposes. In summary, dendritic cells serve as essential orchestrators of immune responses, playing a critical role in both the initiation of protective immunity and the maintenance of immune tolerance.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States